Journal article
Utilization of Multiple Myeloma Treatments in Developing Countries: Systematic Review and Meta-Analysis
Abstract
Introduction: The outcomes of patients diagnosed with multiple myeloma (MM) have improved significantly with the advent of immunomodulatory drugs, proteasome inhibitors, anti-CD38 monoclonal antibodies, and high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation (HSCT). Further advancements include immune-based approaches such as bispecific antibodies and chimeric antigen T-cell receptor therapy. However, most of …
Authors
Almasri J; Hasan B; Tarakji Z; Naffa' FW; Warner L; Mian H; Chakraborty R; Mohyuddin GR; Al Hadidi S
Journal
Blood, Vol. 144, No. Supplement 1,
Publisher
American Society of Hematology
Publication Date
November 5, 2024
DOI
10.1182/blood-2024-206645
ISSN
0006-4971